I 
119TH CONGRESS 
1ST SESSION H. R. 4019 
To amend the Omnibus Crime Control and Safe Streets Act of 1968 to 
establish a grant program for provide access to, and training on the 
administration of, epinephrine products for law enforcement officers, 
and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JUNE 17, 2025 
Ms. GILLEN (for herself and Mr. GARBARINO) introduced the following bill; 
which was referred to the Committee on the Judiciary 
A BILL 
To amend the Omnibus Crime Control and Safe Streets 
Act of 1968 to establish a grant program for provide 
access to, and training on the administration of, epineph-
rine products for law enforcement officers, and for other 
purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as ‘‘Gio’s Law’’. 
VerDate Sep 11 2014 
22:05 Jun 24, 2025
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H4019.IH
H4019
ssavage on LAPJG3WLY3PROD with BILLS
SEC. 2. LAW ENFORCEMENT ACCESS TO EMERGENCY EPI-
NEPHRINE GRANT PROGRAM. 
Title I of the Omnibus Crime Control and Safe 
Streets Act of 1968 (34 U.S.C. 10101 et seq.) is amended 
by adding at the end the following: 
‘‘PART PP—LAW ENFORCEMENT ACCESS TO 
EMERGENCY EPINEPHRINE GRANT PROGRAM 
‘‘SEC. 3061. GRANT AUTHORIZATION. 
‘‘The Attorney General is authorized to make grants 
under this part to States and units of local government 
to— 
‘‘(1) purchase epinephrine products for use by 
State, local, and tribal law enforcement agencies; 
‘‘(2) train State, local, and tribal law enforce-
ment officers, in accordance with the curricula devel-
oped or identified under section 3062. 
‘‘SEC. 3062. STANDARDIZED TRAINING. 
‘‘Not later than 180 days after the date of enactment 
of this part, the Attorney General shall develop a training 
curricula, or identify effective existing training curricula, 
to train law enforcement officer to— 
‘‘(1) recognize the symptoms of an anaphylactic 
reaction; and 
‘‘(2) correctly administer epinephrine products 
to any individual reasonably believed to be having an 
anaphylactic reaction. 
VerDate Sep 11 2014 
22:05 Jun 24, 2025
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H4019.IH
H4019
ssavage on LAPJG3WLY3PROD with BILLS
‘‘SEC. 3063. APPLICATION. 
‘‘The chief executive of a State or unit of local gov-
ernment seeking a grant under this part shall submit to 
the Attorney General an application at such time, in such 
manner, and containing such information as the Attorney 
General may reasonably require, including a certification 
of the State attorney general of the State, or the State 
in which the unit of local government is located, that a 
law enforcement officer who is authorized in that jurisdic-
tion to administer epinephrine products to any individual 
reasonably believed to be having an anaphylactic reaction 
is protected from civil liability arising from administering 
such a product. 
‘‘SEC. 3064. DEFINITION. 
‘‘In this part, the term ‘epinephrine product’ 
means— 
‘‘(1) an epinephrine auto-injector; and 
‘‘(2) a product that facilitates the administra-
tion of epinephrine other than by injection. 
‘‘SEC. 3065. AUTHORIZATION OF APPROPRIATIONS. 
‘‘There is authorized to be appropriated $25,000,000 
to carry out this part for each of fiscal years 2026 through 
2030.’’. 
VerDate Sep 11 2014 
22:05 Jun 24, 2025
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H4019.IH
H4019
ssavage on LAPJG3WLY3PROD with BILLS
SEC. 3. REPORT ON ADMINISTRATION OF EPINEPHRINE BY 
LAW ENFORCEMENT OFFICERS. 
On an annual basis, the Attorney General, acting 
through the Director of the Bureau of Justice Statistics, 
shall submit to Congress and make publicly available, data 
on the frequency of the administration of epinephrine 
products (as such term is defined in section 3064 of title 
I of the Omnibus Crime Control and Safe Streets Act of 
1968) by Federal, State, local, and tribal law enforcement 
officers. 
SEC. 4. INTERAGENCY PUBLIC AWARENESS AND OUT-
REACH CAMPAIGN. 
Not later than 180 days after the date of enactment 
of this Act, the Attorney General, in collaboration with 
the Secretary of Health and Human Services, shall design 
and implement a public awareness campaign to educate 
members of the public about— 
(1) the symptoms of an anaphylactic reaction; 
and 
(2) the role of law enforcement officers and 
first responders in administering epinephrine prod-
ucts. 
Æ 
VerDate Sep 11 2014 
22:05 Jun 24, 2025
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\H4019.IH
H4019
ssavage on LAPJG3WLY3PROD with BILLS